11 unchanged sentences
4.1 Form of Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.1 to the company’s Current Report on Form 8-K filed with the SEC on February 15, 2023).
−Removed: 10.1 Securities Purchase Agreement dated as of February 15, 2023 (incorporated by reference to Exhibit 10.1 to the company’s Current Report on Form 8-K filed with the SEC on February 15, 2023).
−Removed: 10.2 Convertible Promissory Note by and between ImmunityBio, Inc.
−Removed: and Nant Capital, LLC dated as of March 31, 2023 (incorporated by reference to Exhibit 10.1 to the company ’ s Current Report on Form 8-K filed with the SEC on March 31, 2023 ) .
+Added: 10.1 Promissory Note between ImmunityBio, Inc.
+Added: and Nant Capital, LLC dated June 13, 2023 (incorporated by reference to Exhib it 10.1 to the company ’ s Current Report on F orm 8-K fi led with the SEC on June 14, 2023) .
+Added: 10.2* Extension of Commercial Lease by and between 605 Doug St, LLC and ImmunityBio, Inc., dated June 30, 2023 .
31.1* Rule 13a-14(a)/15(d)-14(a) Certification of Principal Executive Officer.
16 unchanged sentences
IMMUNITYBIO, INC.
+Added: August 8, 2023
/s/ Richard Adcock
2 unchanged sentences
(Principal Executive Officer)
+Added: August 8, 2023
Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.